Skip to main content

11 July 2025

Last updated: Thursday 10 July 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Developing radionuclide PARP inhibitors

Sunday 22 November 2020

Interviewee/Contributor

Greg Mullen

Organisation

Theragnostics Ltd

Organisations

MRC Technology
Adrenomed AG
Biotec Pharmacon ASA
Food and Drug Administration
Forbion Capital Partners
Independent consultant
Evonetix Ltd
Roche Group
ALK-Abelló A/S
Versant Ventures

Interviewees and Contributers

Ralf Schmid and Emma Harvey
Jennifer Cubino
Nigel Gaymond
Sander Slootweg
Fredrik Y Frejd
Peter Marks
Rosie Bannister
Simon Ellison
Piet Wigerinck and Walid Abi-Saab

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Louise Peacock joins Aravax

Saturday 5 July 2025

Hans Menssen joins Priothera

Saturday 5 July 2025

Filippa Stenberg joins Mölnlycke Health Care

Saturday 5 July 2025

Commit Biologics appoints scientific advisory board

Saturday 5 July 2025

Cristina Csimma joins Asgard Therapeutics

Saturday 5 July 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form